Breaking News

Versiti Acquires Pearl Pathways

Acquisition accelerates the organization's life science product development capability.

Versiti, a company involved in blood health innovation, acquired Pearl Pathways, an advisor and partner for enabling innovative and expedited life science product development. Indianapolis-based Pearl Pathways is a full-service life science consulting firm, providing regulatory affairs, quality compliance, and niche CRO services. Pearl also has an independent, AHRPP accredited IRB supporting all aspects of human research. The organization supports biopharmaceutical, medical device, and diagno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters